LivaNova PLC

LIVN Healthcare Medical Devices

LivaNova PLC’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 10.7% from fiscal 2024. In the quarter to June 2026, revenue grew 10.8%, EPS grew 296.0%, free cash flow fell 26.7% and total debt fell 31.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

77.60 0.90 −1.15%
Market cap
$4.3B
P/E
22.5×
Fwd P/E
26.0×
Dividend yield
—
F-score
4/9
Altman Z
1.74
Beneish M
−3.30
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
8 6 4 5

+8 more TTM periods

ROE
15.40% 9.54% (19.24%) (17.63%)
ROA
7.33% 4.22% (9.49%) (8.56%)
ROIC
10.63% 12.52% 13.24% 12.81%
Return on Tangible Assets
31.88% 21.12% (45.22%) (44.56%)
Average Days of Receivables
57.37 58.38 56.80 57.25
Free Cash Flow per Share
2.83 3.08 3.31 3.51
Free Cash Flow
155.59 168.32 180.57 191.52
Other line items

Show all line items

Columns are period end dates